Product Program year 2025 Source: CMS Open Payments

Cytoflex

Device Devices

Open in the dashboard

General payments

$17,794,609

47 payments

Research payments

$0

0 payments

Through program year 2025, $17,794,609 in general payments and $0 in research payments were reported against Cytoflex (Devices).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $3,688,943 6
2024 General $3,283,997 7
2023 General $3,660,697 13
2022 General $3,701,771 7
2021 General $3,459,200 14

Breakdown

Who paid General payments · program years 2021–2025
  1. Beckman Coulter, Inc. $17,794,609 47 payments
Top recipients General payments · program year 2025
  1. John Pesando Hematology & Oncology · Seattle, WA $2,742,990 74% · 2 payments
  2. Dana-Farber Cancer Institute Teaching hospital · MA $945,954 26% · 4 payments

Each share is of general payments naming this product in 2025.

Specialties paid General payments · program year 2025
  1. Hematology & Oncology Internal Medicine $2,742,990 100% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Washington $2,742,990 74% · 1 recipient
  2. Massachusetts $945,954 26% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

47 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record